United States · Platforms & data · Investing.com

Stifel reiterates Buy rating on LB Pharmaceuticals stock at $53

Published by Investing.com · United States 3 h ago

Read the full article on Investing.com Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.investing.com)

Also worth reading

The Motley Fool

Should You Forget VOO and Buy This Overlooked ETF Instead?

Citi: Early Q3 earnings results point to another quarter of strong profit growth

Heckler disrupts Nvidia CEO Huang’s speech at Berlin conference

Best Tech Stocks Right Now

Meta Muse closes dangerous privacy loophole after researchers exploit it

Chipotle downgraded to Hold from Buy at TD Cowen